Clinical Efficacy and Changes of Urothelial Dysfunction after Repeated Detrusor Botulinum Toxin A Injections in Chronic Spinal Cord-Injured Bladder
Chornic spinal cord injury (SCI) will induce bladder urothelium dysfunction. This study investigated the therapeutic effects on urothelial dysfunction after repeated detrusor injections of onabotulinumtoxinA (BoNT-A) in SCI patients with neurogenic detrusor overactivity (NDO). Twenty chronic suprasa...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-05-01
|
Series: | Toxins |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6651/8/6/164 |
_version_ | 1818038762996760576 |
---|---|
author | Sheng-Fu Chen Chia-Hwei Chang Hann-Chorng Kuo |
author_facet | Sheng-Fu Chen Chia-Hwei Chang Hann-Chorng Kuo |
author_sort | Sheng-Fu Chen |
collection | DOAJ |
description | Chornic spinal cord injury (SCI) will induce bladder urothelium dysfunction. This study investigated the therapeutic effects on urothelial dysfunction after repeated detrusor injections of onabotulinumtoxinA (BoNT-A) in SCI patients with neurogenic detrusor overactivity (NDO). Twenty chronic suprasacral SCI patients with NDO were enrolled. The patients received 300 U BoNT-A injection into the detrusor every six months. The urothelium was assessed by cystoscopic biopsy at baseline and six months after each BoNT-A treatment. Immunofluorescence staining for urothelial dysfunction, including E-cadherin, zonula occludens-1 (ZO-1), tryptase for mast cell activity, and urothelial apoptosis were investigated. The outcome of urothelial dysfunction parameters after BoNT-A injection were compared between baseline and six months after each treatment. Repeated 300 U BoNT-A injections showed a sustained decrease of detrusor pressure compared with baseline. After three repeated BoNT-A detrusor injections, significantly greater distributions of E-cadherin (p = 0.042) and ZO-1 (p = 0.003) expressions, but no significant changes, of urothelial apoptosis and mast cell activation were found after repeated BoNT-A therapy. Urothelial dysfunction, such as adhesive and junction protein concentrations in SCI patients’ bladders, recovered after three repeated cycles of BoNT-A treatment. The therapeutic effects sustained. However, urothelial inflammation and apoptosis after SCI were not significantly improved after three repeated BoNT-A injections. |
first_indexed | 2024-12-10T07:47:54Z |
format | Article |
id | doaj.art-790e4ce27ded4c13ab3a64c7741ec28d |
institution | Directory Open Access Journal |
issn | 2072-6651 |
language | English |
last_indexed | 2024-12-10T07:47:54Z |
publishDate | 2016-05-01 |
publisher | MDPI AG |
record_format | Article |
series | Toxins |
spelling | doaj.art-790e4ce27ded4c13ab3a64c7741ec28d2022-12-22T01:57:08ZengMDPI AGToxins2072-66512016-05-018616410.3390/toxins8060164toxins8060164Clinical Efficacy and Changes of Urothelial Dysfunction after Repeated Detrusor Botulinum Toxin A Injections in Chronic Spinal Cord-Injured BladderSheng-Fu Chen0Chia-Hwei Chang1Hann-Chorng Kuo2Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, 707, Section 3, Chung Yang Road, Hualian 970, TaiwanDepartment of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, 707, Section 3, Chung Yang Road, Hualian 970, TaiwanDepartment of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, 707, Section 3, Chung Yang Road, Hualian 970, TaiwanChornic spinal cord injury (SCI) will induce bladder urothelium dysfunction. This study investigated the therapeutic effects on urothelial dysfunction after repeated detrusor injections of onabotulinumtoxinA (BoNT-A) in SCI patients with neurogenic detrusor overactivity (NDO). Twenty chronic suprasacral SCI patients with NDO were enrolled. The patients received 300 U BoNT-A injection into the detrusor every six months. The urothelium was assessed by cystoscopic biopsy at baseline and six months after each BoNT-A treatment. Immunofluorescence staining for urothelial dysfunction, including E-cadherin, zonula occludens-1 (ZO-1), tryptase for mast cell activity, and urothelial apoptosis were investigated. The outcome of urothelial dysfunction parameters after BoNT-A injection were compared between baseline and six months after each treatment. Repeated 300 U BoNT-A injections showed a sustained decrease of detrusor pressure compared with baseline. After three repeated BoNT-A detrusor injections, significantly greater distributions of E-cadherin (p = 0.042) and ZO-1 (p = 0.003) expressions, but no significant changes, of urothelial apoptosis and mast cell activation were found after repeated BoNT-A therapy. Urothelial dysfunction, such as adhesive and junction protein concentrations in SCI patients’ bladders, recovered after three repeated cycles of BoNT-A treatment. The therapeutic effects sustained. However, urothelial inflammation and apoptosis after SCI were not significantly improved after three repeated BoNT-A injections.http://www.mdpi.com/2072-6651/8/6/164botulinum toxin Aurothelial dysfunctionspinal cord injury |
spellingShingle | Sheng-Fu Chen Chia-Hwei Chang Hann-Chorng Kuo Clinical Efficacy and Changes of Urothelial Dysfunction after Repeated Detrusor Botulinum Toxin A Injections in Chronic Spinal Cord-Injured Bladder Toxins botulinum toxin A urothelial dysfunction spinal cord injury |
title | Clinical Efficacy and Changes of Urothelial Dysfunction after Repeated Detrusor Botulinum Toxin A Injections in Chronic Spinal Cord-Injured Bladder |
title_full | Clinical Efficacy and Changes of Urothelial Dysfunction after Repeated Detrusor Botulinum Toxin A Injections in Chronic Spinal Cord-Injured Bladder |
title_fullStr | Clinical Efficacy and Changes of Urothelial Dysfunction after Repeated Detrusor Botulinum Toxin A Injections in Chronic Spinal Cord-Injured Bladder |
title_full_unstemmed | Clinical Efficacy and Changes of Urothelial Dysfunction after Repeated Detrusor Botulinum Toxin A Injections in Chronic Spinal Cord-Injured Bladder |
title_short | Clinical Efficacy and Changes of Urothelial Dysfunction after Repeated Detrusor Botulinum Toxin A Injections in Chronic Spinal Cord-Injured Bladder |
title_sort | clinical efficacy and changes of urothelial dysfunction after repeated detrusor botulinum toxin a injections in chronic spinal cord injured bladder |
topic | botulinum toxin A urothelial dysfunction spinal cord injury |
url | http://www.mdpi.com/2072-6651/8/6/164 |
work_keys_str_mv | AT shengfuchen clinicalefficacyandchangesofurothelialdysfunctionafterrepeateddetrusorbotulinumtoxinainjectionsinchronicspinalcordinjuredbladder AT chiahweichang clinicalefficacyandchangesofurothelialdysfunctionafterrepeateddetrusorbotulinumtoxinainjectionsinchronicspinalcordinjuredbladder AT hannchorngkuo clinicalefficacyandchangesofurothelialdysfunctionafterrepeateddetrusorbotulinumtoxinainjectionsinchronicspinalcordinjuredbladder |